CY1106877T1 - C1-συμμετρικοι δισφωσφινης συνδετηρες και χρηση αυτων στην ασυμμετρη συνθεση pregabalin - Google Patents

C1-συμμετρικοι δισφωσφινης συνδετηρες και χρηση αυτων στην ασυμμετρη συνθεση pregabalin

Info

Publication number
CY1106877T1
CY1106877T1 CY20071101203T CY071101203T CY1106877T1 CY 1106877 T1 CY1106877 T1 CY 1106877T1 CY 20071101203 T CY20071101203 T CY 20071101203T CY 071101203 T CY071101203 T CY 071101203T CY 1106877 T1 CY1106877 T1 CY 1106877T1
Authority
CY
Cyprus
Prior art keywords
symmetric
bissophinal
asymmetric
connectors
pregabalin
Prior art date
Application number
CY20071101203T
Other languages
English (en)
Inventor
Jian Bao
Vladimir Genukh Beylin
Derek Joseph Greene
Garrett Hoge
William Scott Kissel
Eugene Marlattmark
Derek Andrew Pflum
He-Ping Wu
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34961258&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1106877(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of CY1106877T1 publication Critical patent/CY1106877T1/el

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22—Organic complexes
    • B01J31/2282—Unsaturated compounds used as ligands
    • B01J31/2295—Cyclic compounds, e.g. cyclopentadienyls
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00—Asymmetric syntheses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30—Preparation of optical isomers
    • C07C227/32—Preparation of optical isomers by stereospecific synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/16—Preparation of optical isomers
    • C07C231/18—Preparation of optical isomers by stereospecific synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/5027—Polyphosphines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/5045—Complexes or chelates of phosphines with metallic compounds or metals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/53—Organo-phosphine oxides; Organo-phosphine thioxides
    • C07F9/5329—Polyphosphine oxides or thioxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5463—Compounds of the type "quasi-phosphonium", e.g. (C)a-P-(Y)b wherein a+b=4, b>=1 and Y=heteroatom, generally N or O
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/60—Reduction reactions, e.g. hydrogenation
    • B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
    • B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
    • B01J2231/645—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of C=C or C-C triple bonds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82—Metals of the platinum group
    • B01J2531/822—Rhodium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)

Abstract

Αποκαλύπτονται υλικά και μέθοδοι για παρασκευή (S)-(+)-3-(αμινομεθυλ)-5-μεθυλεξανοϊκού οξέος και συντακτικώς συναφών ενώσεων μέσω εναντιοεκλεκτικής υδρογόνωσης προχηλικών ολεφινών. Η μέθοδος χρησιμοποιεί νέους χηλικούς καταλύτες οι οποίοι συμπεριλαμβάνουν C1-συμμετρικούς δισφωσφίνης συνδετήρες που συνδέονται προς μέταλλα μετάπτωσης.
CY20071101203T 2004-03-12 2007-09-17 C1-συμμετρικοι δισφωσφινης συνδετηρες και χρηση αυτων στην ασυμμετρη συνθεση pregabalin CY1106877T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55258604P 2004-03-12 2004-03-12
US58651204P 2004-07-09 2004-07-09
EP05708733A EP1727620B1 (en) 2004-03-12 2005-03-09 C1-symmetric bisphosphine ligands and their use in the asymmetric synthesis of pregabalin

Publications (1)

Publication Number Publication Date
CY1106877T1 true CY1106877T1 (el) 2012-09-26

Family

ID=34961258

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101203T CY1106877T1 (el) 2004-03-12 2007-09-17 C1-συμμετρικοι δισφωσφινης συνδετηρες και χρηση αυτων στην ασυμμετρη συνθεση pregabalin

Country Status (21)

Country Link
US (2) US20050228190A1 (el)
EP (1) EP1727620B1 (el)
JP (1) JP2007528893A (el)
KR (2) KR100823758B1 (el)
AR (1) AR051533A1 (el)
AT (1) ATE371496T1 (el)
AU (1) AU2005221401A1 (el)
BR (1) BRPI0508615A (el)
CA (1) CA2559086A1 (el)
CY (1) CY1106877T1 (el)
DE (1) DE602005002253T2 (el)
DK (1) DK1727620T3 (el)
ES (1) ES2292107T3 (el)
IL (1) IL177482A0 (el)
NO (1) NO20063574L (el)
NZ (1) NZ549004A (el)
PL (1) PL1727620T3 (el)
PT (1) PT1727620E (el)
RU (1) RU2335342C2 (el)
TW (1) TWI299990B (el)
WO (1) WO2005087370A1 (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9710536A (pt) 1996-07-24 1999-08-17 Warner Lambert Co Isobutilgaba e seus derivados para o tratamento da dor
CN101160281A (zh) 2005-04-06 2008-04-09 特瓦制药工业有限公司 结晶形态的普瑞巴林
CN101300224A (zh) * 2005-04-11 2008-11-05 特瓦制药工业有限公司 制备(s)-普瑞巴林的方法
US7488846B2 (en) * 2005-04-11 2009-02-10 Teva Pharmaceuical Industries Ltd. Pregabalin free of lactam and a process for preparation thereof
DE602006017995D1 (de) * 2005-05-10 2010-12-16 Teva Pharma Verfahren zur herstellung von pregabalin und salzen daraus
MX2007000525A (es) 2005-05-10 2007-03-28 Teva Pharma Pregabalina libre de acido isobutilglutarico y un proceso para la preparacion de ella.
EP1879854B1 (en) * 2005-05-10 2011-09-07 Teva Pharmaceutical Industries Ltd Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
WO2007035890A1 (en) * 2005-09-19 2007-03-29 Teva Pharmaceutical Industries Ltd. An asymmetric synthesis of ( s ) - ( + ) -3- (aminomethyl) -5-methylhexanoic acid
US20070259917A1 (en) * 2006-04-24 2007-11-08 Kansal Vinod K Processes for the synthesis of 3-isobutylglutaric acid
US7462738B2 (en) * 2006-05-24 2008-12-09 Teva Pharmaceutical Industries Ltd. Processes for the preparation of R-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof
EP2071032A3 (en) * 2006-05-31 2009-07-08 Teva Pharmaceutical Industries Ltd The use of enzymatic resolution for the preparation of intermediates of pregabalin
WO2007143152A2 (en) * 2006-05-31 2007-12-13 Teva Pharmaceutical Industries Ltd. Preparation of (s)-pregabalin-nitrile
GB0700622D0 (en) * 2007-01-12 2007-02-21 Johnson Matthey Plc Process for preparing cationic rhodium complexes
MX2008014759A (es) * 2007-03-22 2009-03-09 Teva Pharma Sintesis del acido (s)-(+)-3-(aminometil)-5-metil hexanoico.
KR20090101462A (ko) * 2007-10-03 2009-09-28 테바 파마슈티컬 인더스트리즈 리미티드 프레가발린-4-엘리미네이트, 프레가발린 5-엘리미네이트, 기준 마커 및 표준물로서의 이들의 용도, 및 이들을 낮은 수준으로 함유하는 프레가발린의 제조 방법
CA2724828C (en) 2008-05-21 2016-01-12 Sandoz Ag Process for the stereoselective enzymatic hydrolysis of 5-methyl-3-nitromethyl-hexanoic acid ester
KR20100107500A (ko) * 2008-06-23 2010-10-05 테바 파마슈티컬 인더스트리즈 리미티드 (ｓ) 또는 (ｒ)-이소-부틸-글루타릭 에스테르의 입체선택적 효소 합성방법
GB0812290D0 (en) * 2008-07-04 2008-08-13 Johnson Matthey Plc Process for preparing cationic rhodium complexes
US8552212B2 (en) 2009-11-05 2013-10-08 Boehringer Ingelheim International Gmbh Chiral phosphorus ligands
EP2534161A1 (en) 2010-02-12 2012-12-19 Enantia, S.L. Enantiomerically enriched aminodiphosphines as ligands for the preparation of catalysts for asymmetric synthesis
GB201103092D0 (en) * 2011-02-23 2011-04-06 Univ Dublin Process
WO2016075082A1 (en) 2014-11-10 2016-05-19 Sandoz Ag Stereoselective reductive amination of alpha-chiral aldehydes using omega-transaminases for the synthesis of precursors of pregabalin and brivaracetam
US10196413B2 (en) 2016-12-06 2019-02-05 Boehringer Ingelheim International Gmbh Chiral dihydrobenzoazaphosphole ligands and synthesis thereof
EP3551638A2 (en) 2016-12-06 2019-10-16 Boehringer Ingelheim International GmbH Novel chiral dihydrobenzooxaphosphole ligands and synthesis thereof
JP6949903B2 (ja) 2019-06-24 2021-10-13 日本化学工業株式会社 光学活性ビスホスフィノメタン及びその製造方法、並びに遷移金属錯体及び不斉触媒
CN111647020A (zh) * 2020-04-09 2020-09-11 宁波赜军医药科技有限公司 一种膦氧双齿配体的合成方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197819B1 (en) * 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
US5616793A (en) * 1995-06-02 1997-04-01 Warner-Lambert Company Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid
US5637767A (en) * 1995-06-07 1997-06-10 Warner-Lambert Company Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
BR9710536A (pt) * 1996-07-24 1999-08-17 Warner Lambert Co Isobutilgaba e seus derivados para o tratamento da dor
US6329429B1 (en) * 1997-06-25 2001-12-11 Warner-Lambert Company Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases
US6194459B1 (en) * 1997-08-19 2001-02-27 Warner-Lambert Company Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants
US6127418A (en) * 1997-08-20 2000-10-03 Warner-Lambert Company GABA analogs to prevent and treat gastrointestinal damage
AU8668598A (en) * 1997-08-20 1999-03-08 University Of Oklahoma, The Gaba analogs to prevent and treat gastrointestinal damage
AU765038B2 (en) * 1998-07-09 2003-09-04 Warner-Lambert Company Method for the treatment of insomnia
PL345340A1 (en) * 1998-07-09 2001-12-17 Warner Lambert Co Compositions comprising gaba analogs and caffeine
WO2000023067A1 (en) * 1998-10-16 2000-04-27 Warner-Lambert Company Method for the treatment of mania and bipolar disorder
HU228815B1 (en) * 2000-01-27 2013-05-28 Warner Lambert Co Asymmetric synthesis of pregabalin
MXPA02001147A (es) * 2001-03-19 2004-04-21 Warner Lambert Co Sintesis de ligandos bisfosina no-c2-simetricos como catalizadores para la hidrogenacion asimetrica.
US6696058B2 (en) * 2002-01-29 2004-02-24 Laclede, Inc. Aqueous enzymatic denture adhesives
NI200300043A (es) * 2002-03-28 2003-11-05 Warner Lambert Co AMINOACIDOS CON AFINIDAD POR LA PROTEINA a2DELTA.

Also Published As

Publication number Publication date
KR20060118603A (ko) 2006-11-23
PL1727620T3 (pl) 2007-12-31
AR051533A1 (es) 2007-01-24
BRPI0508615A (pt) 2007-07-31
IL177482A0 (en) 2006-12-10
DE602005002253D1 (de) 2007-10-11
NZ549004A (en) 2009-04-30
DE602005002253T2 (de) 2008-05-29
RU2006132505A (ru) 2008-03-27
WO2005087370A1 (en) 2005-09-22
PT1727620E (pt) 2007-11-05
EP1727620B1 (en) 2007-08-29
ATE371496T1 (de) 2007-09-15
EP1727620A1 (en) 2006-12-06
TWI299990B (en) 2008-08-21
KR100847922B1 (ko) 2008-07-22
NO20063574L (no) 2006-09-05
US20050228190A1 (en) 2005-10-13
KR20070074671A (ko) 2007-07-12
ES2292107T3 (es) 2008-03-01
KR100823758B1 (ko) 2008-04-21
JP2007528893A (ja) 2007-10-18
TW200600090A (en) 2006-01-01
DK1727620T3 (da) 2007-12-03
RU2335342C2 (ru) 2008-10-10
US20090124820A1 (en) 2009-05-14
AU2005221401A1 (en) 2005-09-22
CA2559086A1 (en) 2005-09-22

Similar Documents

Publication Publication Date Title
CY1106877T1 (el) C1-συμμετρικοι δισφωσφινης συνδετηρες και χρηση αυτων στην ασυμμετρη συνθεση pregabalin
EA200800908A1 (ru) Получение прегабалина и родственных соединений
IL186280A0 (en) An asymmetric synthesis of (s)-(+)-3-(aminomethyl)-5-methylhexanoic acid
ATE356136T1 (de) Verfahren zur herstellung von 1,2- diaminocyclohexan-platin(ii)-komplexen
ATE486841T1 (de) Verfahren zur herstellung von pregabalin und salzen daraus
ATE360647T1 (de) Verfahren zur aufreinigung von il-18-bindendem protein
ATE352784T1 (de) Verfahren zum screenen für gpr40-liganden
ATE448863T1 (de) Verfahren zur gewinnung von gallium-68 und dessen verwendung und hilfsmittel zur durchführung dieses verfahrens
ATE529433T1 (de) Verfahren zur reinigung eines il-18-bindenden proteins
ATE348838T1 (de) Neuartige geruchsrezeptoren in drosophila
ATE525466T1 (de) Verfahren und testkit zur trennung, aufreinigung und wiedergewinnung von lang- und kurzkettigen nukleinsäuren
DE602005019593D1 (de) Verfahren zur reinigung von radiomarkierten produkinem feststoffträger
ATE513840T1 (de) Verfahren zur herstellung optisch aktiver diphosphane
ATE423316T1 (de) Verfahren zum nachweis ungenügender bindung von magnesium an zelluläre membranen zum krankheitsnachweis
ATE516266T1 (de) Verfahren zur isomerisierung von cis-2- pentennitril zu trans-3-pentennitril
ATE367372T1 (de) Verfahren zur herstellung von (r)-salbutamol
WO2005067437A3 (en) Methods and compositions for in vitro and in vivo use of parallel stranded hairpins and triplex structures as nucleic acid ligands
ATE540967T1 (de) Verfahren zur reinigung von proteinen
DE50300920D1 (de) Ferrocenylliganden und ein verfahren zur herstellung solcher liganden
WO2000077208A3 (en) Gustatory receptors in drosophila
WO2004002462A3 (en) Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder
ATE405827T1 (de) Screening-verfahren
ATE338050T1 (de) Verfahren zur asymmetrischen hydrierung von ketocarbonsäureestern
TW200621691A (en) Chiral 3-halophthalic acid derivatives
DK1644401T3 (da) Forbedret fremgangsmåde til fastfasesyntese